Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Search

Page Path
HOME > Search
3 "pharmacist"
Filter
Filter
Article category
Publication year
Review Article
Neurosurgery
Interdisciplinary collaboration in neurocritical care management
Hyunchul Jung, Seung Bin Kim, Seungjoo Lee, Moinay Kim
Acute Crit Care. 2026;41(2):226-236.   Published online January 29, 2026
DOI: https://doi.org/10.4266/acc.003275
  • 3,012 View
  • 113 Download
AbstractAbstract PDF
The complexity of neurocritical care requires a shift from traditional, discipline-specific practice toward a collaborative, interdisciplinary model. This review explores the conceptual and practical framework of interdisciplinary collaboration in neuro-intensive care units, examining the roles of key specialists including neurosurgeons, neurologists, intensivists, pharmacists, nutritionists, and rehabilitation experts. We discuss the benefits of coordinated care in improving patient-centered outcomes, reducing morbidity and mortality, and enhancing intensive care unit efficiency. Emerging evidence supports the integration of neurointensivists, structured communication tools, and team-based decision-making as essential components of modern critical care delivery. This article provides a comprehensive review of current strategies and proposes directions for advancing interdisciplinary practice in neurocritical care settings.
Original Articles
Pharmacology
Pharmacotherapeutic Problems and Pharmacist Interventions in a Medical Intensive Care Unit
Tae Yun Park, Sang-Min Lee, Sung Eun Kim, Ka-Eun Yoo, Go Wun Choi, Yun Hee Jo, Yoonsook Cho, Hyeon Joo Hahn, Jinwoo Lee, A Jeong Kim
Korean J Crit Care Med. 2015;30(2):82-88.   Published online May 31, 2015
DOI: https://doi.org/10.4266/kjccm.2015.30.2.82
  • 11,296 View
  • 194 Download
  • 4 Crossref
AbstractAbstract PDF
Background
Interest in pharmacist participation in the multidisciplinary intensive care team is increasing. However, studies examining pharmacist interventions in the medical intensive care unit (MICU) are limited in Korea. The aim of this study was to describe the current status of pharmacist interventions and to identify common pharmacologic problems requiring pharmacist intervention in the MICU. Methods: Between September 2013 and August 2014, a retrospective, observational study was conducted in the 22-bed MICU at a university hospital. Data were obtained from two trained pharmacists who participated in MICU rounds three times a week. In addition to patient characteristics, data on the cause, type, related drug, and acceptance rate of interventions were collected. Results: In 340 patients, a total of 1211 pharmacologic interventions were performed. The majority of pharmacologic interventions were suggested by pharmacists at multidisciplinary rounds in the MICU. The most common pharmacologic interventions were adjustment of dosage and administration (n = 328, 26.0%), followed by parenteral/enteral nutritional support (n = 228, 18.1%), the provision of drug information (n = 228, 18.1%), and advice regarding pharmacokinetics (n = 118, 9.3%). Antimicrobial agents (n = 516, 42.6%) were the most frequent type of drug associated with pharmacist interventions. The acceptance rate of interventions was 84.1% with most accepted by physicians within 24 hours (n = 602, 92.8%). Conclusions: Medication and nutritional problems are frequently encountered pharmacotherapeutic problems in the MICU. Pharmacist interventions play an important role in the management of these problems.

Citations

Citations to this article as recorded by  
  • Clinical Outcomes Associated with the Implementation of a Dedicated Clinical Pharmacy Service in a Resource-Limited Neurocritical Intensive Care Unit
    Eunyoung Sa, Yoonsook Cho, Sung Yun Suh, Tae Eun Park, Sandy Jeong Rhie
    Hospital Pharmacy.2025; 60(2): 132.     CrossRef
  • Analysis of Pharmacists’ Prescription Reviews for Outpatients at a Tertiary Hospital
    Se Yeong Jeong, Hyo Jung Park, Sun Young Kim, Seon Young Chung, Myung Sook Min
    Journal of Korean Society of Health-System Pharmacists.2024; 41(3): 266.     CrossRef
  • Characterization of drug‐related problems and evaluation of pharmacist interventions in the cardiovascular intensive care settings in Thailand
    Phannita Wattanaruengchai, Junporn Kongwatcharapong, Surakit Nathisuwan
    JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2023; 6(5): 488.     CrossRef
  • A Systematic Review of Outcomes Research in the Hospital Pharmacists’ Interventions in South Korea
    So Young Lee, Eun Cho
    Korean Journal of Clinical Pharmacy.2019; 29(3): 193.     CrossRef
Effect of Clinical Pharmacist Interventions on Prevention of Adverse Drug Events in Surgical Intensive Care Unit
Minkyong Kang, Ahjeong Kim, Yoonsook Cho, Hyangsook Kim, Hyesook Lee, Yong Jae Yu, Hannah Lee, Kyu Joo Park, Hee pyoung Park
Korean J Crit Care Med. 2013;28(1):17-24.
DOI: https://doi.org/10.4266/kjccm.2013.28.1.17
  • 5,896 View
  • 111 Download
  • 5 Crossref
AbstractAbstract PDF
BACKGROUND
A pharmacist's participation in medical rounds in intensive care unit (ICU) is becoming popular nowadays. In this study, we investigated the effect of pharmacologic intervention by a pharmacist's participation in medical round in ICU on prevention of adverse drug events (ADEs).
METHODS
From March 2011 to July 2011, the intervention data were obtained by participating in medical round two or three times a week, and by reviewing electronic medical records of patients admitted to surgical ICU. The incidence, cause, and type of ADEs were noted, respectively. Expected cost avoidance was calculated from interventions, which were considered to be preventive of ADEs. The acceptance rate of pharmacologic interventions was noted.
RESULTS
Among 2781 patients, a total of 159 intervention data were collected in 90 patients. Recommendation for drug dosage adjustment or monitoring in patients with potential overdose and sub-therapeutic dose made up 82% of the total interventions. In 8% of interventions, initiation of drug therapy was recommended. 83% of the interventions were accepted and the acceptance rate of interventions within 24 hrs was 58%. The rate of the interventions, which were considered to be preventive of ADEs was 62%. Expected cost reduction obtained by preventing ADEs was 25,867,083 Won during a 5-month period.
CONCLUSIONS
A pharmacist's participation in physician rounds in ICU was associated with prevention of ADEs and subsequent reduction of the cost in drug therapy.

Citations

Citations to this article as recorded by  
  • Economic Impact of Clinical Pharmacist Interventions in an Adult Intensive Care Unit
    Eunkyeong Choi, Su Eun Lee, Dong Young Park, Sung Jin Bae, Kwangha Lee
    Journal of Korean Society of Health-System Pharmacists.2026; 43(1): 49.     CrossRef
  • What is impacting clinical pharmacists’ participation in an interprofessional ward round: a thematic analysis of a national survey
    Dona Babu, Sally Marotti, Debra Rowett, Renly Lim, Alice Wisdom, Lisa Kalisch Ellett
    Journal of Interprofessional Care.2024; 38(3): 444.     CrossRef
  • A Systematic Review of Outcomes Research in the Hospital Pharmacists’ Interventions in South Korea
    So Young Lee, Eun Cho
    Korean Journal of Clinical Pharmacy.2019; 29(3): 193.     CrossRef
  • Effects of Medication Reconciliation and Cost Avoidance Analysis by Clinical Pharmacists in a Neurocritical Care Unit
    Ui Sang Cho, Young Joo Song, Young Mi Jung, Kyung Suk Choi, Eunsook Lee, Euni Lee, Moon-Ku Han
    Journal of Neurocritical Care.2018; 11(2): 110.     CrossRef
  • Pharmacotherapeutic Problems and Pharmacist Interventions in a Medical Intensive Care Unit
    Tae Yun Park, Sang-Min Lee, Sung Eun Kim, Ka-Eun Yoo, Go Wun Choi, Yun Hee Jo, Yoonsook Cho, Hyeon Joo Hahn, Jinwoo Lee, A Jeong Kim
    The Korean Journal of Critical Care Medicine.2015; 30(2): 82.     CrossRef
ACC : Acute and Critical Care
© The Korean Society of Critical Care Medicine.
TOP